Shares of Momenta Pharmaceuticals (MNTA) move 16% higher premarket after the company announces...

|About: Momenta Pharmaceuticals, ... (MNTA)|By:, SA News Editor

Shares of Momenta Pharmaceuticals (MNTA) move 16% higher premarket after the company announces it obtained a preliminary injunction against a number of biotech rivals from offering or selling their own generic Lovenox treatment.